Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.00
Bid: 324.00
Ask: 327.00
Change: 6.00 (1.88%)
Spread: 3.00 (0.926%)
Open: 321.00
High: 326.00
Low: 321.00
Prev. Close: 320.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement for sale of a portfolio of NPLs

3 Aug 2020 07:00

RNS Number : 9006U
Bank of Cyprus Holdings PLC
03 August 2020
 

Announcement

 

Agreement for sale of a portfolio of non-performing loans

 

Nicosia, 3 August 2020 

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014.

 

 

 

Bank of Cyprus Holdings Public Limited Company ("BOC Holdings" and, together with its subsidiaries, the "Group") has reached an agreement with funds affiliated with Pacific Investment Management Company LLC ("PIMCO"), for the sale of a portfolio (the "Portfolio") of Non Performing Loans with a gross book value of €916 mn1,2 (known as "Project Helix 2", or the "Transaction").

 

The Portfolio has a contractual balance of €1.46 bn3 and it comprises 22,224 loans, mainly to Retail and SME clients, secured over 5,616 real estate collaterals. The net book value of the assets being sold amounts to €440 mn1. The consideration amounts to 46% of the gross book value and 29% of the contractual balance payable in cash, of which 35% is payable at completion and the remaining 65% is deferred without any conditions attached. The deferred component is payable in three broadly equal instalments over 48 months from completion.

 

The consideration can be increased through an earnout arrangement, depending on the performance of the Portfolio.

 

The Transaction accelerates the Bank's strategy of de-risking its balance sheet, by reducing its stock of NPEs by 24%1 and its NPE ratio by 5 percentage points1. At completion, the Transaction is expected to have an impact of -34 bps1 on the Group's CET 1 ratio. Upon the full repayment of the deferred consideration and without taking account of any positive impact from the earnout, the Transaction is expected to have a +9 bps1 capital impact on the Group's CET 1 ratio. The accounting loss attributable to the Transaction is estimated at c.€68 mn recorded in 2Q2020.

 

The completion of the Transaction is currently estimated to occur in the first half of 2021 and remains subject to a number of conditions, including customary regulatory and other approvals.

 

The Portfolio will be transferred to a licensed Cypriot Credit Acquiring Company (the "CyCAC") by Bank of Cyprus Public Company Limited (the "Bank"). The shares of the CyCAC will then be acquired by certain funds affiliated with PIMCO, the purchaser of the Portfolio.

 

Following a transitional period where servicing will be retained by the Bank, it is intended that the servicing of the Portfolio will be carried out by a third party servicer selected and appointed by the CyCAC. Arrangements in relation to the migration of servicing from the Bank to the servicer, including the timing of the migration, remain under discussion between the parties.

 

The Transaction represents another milestone in the delivery of the Group's core strategy of improving asset quality through the reduction of NPEs. Including Helix 2, the NPE reduction in the first six months of 2020 amounted to €1.3 bn, reducing the NPE ratio to 22%. This includes organic NPE reduction of €278 mn and the completion of the sale of €133 mn primarily retail unsecured NPEs (Velocity 2).

 

The Bank remains fully committed to further de-risking of the balance sheet. In the context of IFRS 9, the Bank estimates additional loan credit losses of €21 mn in 2Q2020, as a result of potential further NPE sales in the future. In 4Q2019 loan credit losses of €75 mn were recorded as a result of the anticipated balance sheet de-risking at the time.

 

The Group's CET1 ratio at 30 June 2020 is expected to remain broadly unchanged compared to the CET 1 ratio of 14.3% as at 31 March 2020, taking account of the capital benefit resulting from the amendments to capital regulations introduced in June 2020.

 

PIMCO is one of the world's premier fixed income investment managers. With its launch in 1971 in Newport Beach, California, PIMCO introduced investors to a total return approach to fixed income investing. In the 45+ years since, the firm continued to bring innovation and expertise to their partnership with clients seeking the best investment solutions. Today PIMCO has offices across the globe and 2,900+ professionals united by a single purpose: creating opportunities for investors in every environment. PIMCO is owned by Allianz SE, a leading global diversified financial services provider.

 

 

Panicos Nicolaou, Group Chief Executive Officer, commented:

 

"I am pleased to announce the signing of Helix 2 today, another significant disposal of non- performing loans by the Bank, despite the challenging market conditions resulting from the outbreak of COVID-19. The combined de-risking actions, including Helix 2, have reduced NPEs in the first six months of 2020 by €1.3 bn. Overall, since the peak in 2014, we have now reduced the stock of NPEs by €12.4 bn4 or 83%4 to €2.6 bn4 and our NPE ratio is reduced to 22%4.

 

We remain committed to further de-risking of the balance sheet and we will continue to seek solutions, both organic and inorganic to achieve this. We will continue to assess the potential to accelerate the decrease in NPEs on our balance sheet through additional sales of NPEs in the future.

 

This transaction marks further progress against delivering on our strategic objectives of becoming a stronger, safer and more focused institution. We are now better positioned to manage the challenges resulting from the impact of the ongoing COVID-19 crisis, and to support the recovery of the Cypriot economy".

 

Morgan Stanley & Co. International plc and KPMG LLP acted as financial advisors, Allen & Overy LLP acted as English legal advisors and Chryssafinis & Polyviou LLC acted as Cypriot legal advisors to the Bank in this Transaction.

 

For further information, please contact Investor Relations at investors@bankofcyprus.com.

 

 

1 Based on the Group Financial Results for the quarter ended 31 March 2020.

2 On balance sheet gross book value of which €903 mn1 relate to non-performing exposures or "NPEs". The gross book value of €916 mn includes properties of €4 mn that will also be transferred to the buyer.

3 As at the portfolio reference date of 30 September 2019.

4 Calculations on a pro forma basis assume completion of the Transaction.

 

Group Profile

 

The Bank of Cyprus Group is the leading banking and financial services group in Cyprus, providing a wide range of financial products and services which include retail and commercial banking, finance, factoring, investment banking, brokerage, fund management, private banking, life and general insurance. The Bank of Cyprus Group operates through a total of 99 branches in Cyprus, of which 15 operate as cash offices. Bank of Cyprus also has representative offices in Russia, Ukraine and China. The Bank of Cyprus Group employs 3,566 staff worldwide. At 31 March 2020, the Group's Total Assets amounted to €20.4 bn and Total Equity was €2.2 bn. The Bank of Cyprus Group comprises Bank of Cyprus Holdings Public Limited Company, its subsidiary Bank of Cyprus Public Company Limited and its subsidiaries.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISUOVVRRUUWRRR
Date   Source Headline
25th Jul 20227:08 amRNSCompletion of Voluntary Staff Exit Plan
6th Jun 20227:00 amRNSTR1 Notification- Senvest
26th May 20227:00 amRNSTR1 Notification - Eaton Vance
23rd May 202210:35 amRNSBoard and Board Committees Composition
23rd May 20227:17 amRNSResolutions of AGM- Replacement
20th May 202212:36 pmRNSResolutions of AGM
19th May 20227:02 amRNSDoc re. (1Q2022 Financial Results Presentation)
19th May 20227:00 amRNS1st Quarter Results
5th May 20229:47 amRNSDate of announcement of 1Q2022 FR
14th Apr 20221:06 pmRNSNotice of AGM
13th Apr 202212:41 pmRNSPDMR Transaction - Ioardanou
7th Apr 202212:53 pmRNSPillar 3 Disclosures for 2021
4th Apr 20227:27 amRNSTR1 Notification of Major Holdings- Caius
30th Mar 202210:57 amRNSPDMR Notification of Transaction – Iordanou
30th Mar 20227:05 amRNSBOC Annual Financial Report 2021 Announcement
30th Mar 20227:03 amRNSBOCH Annual Financial Report 2021 Announcement
30th Mar 20227:02 amRNSDoc re. (FY2021 Investor Presentation)
30th Mar 20227:00 amRNSFY2021 Group Financial Results
18th Mar 202211:46 amRNSNotice of Results
17th Mar 20229:37 amRNSRestrictive measures and sanctions against Russia
7th Mar 20224:41 pmRNSSecond Price Monitoring Extn
7th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Feb 20227:02 amRNSDoc re. Prelim FY2021 Investor Presentation
21st Feb 20227:00 amRNSFY2021 Prel. Group FR and MT Strategic Targets
18th Feb 20228:22 amRNSTR1 Major Holdings Notification -Senvest
8th Feb 20227:00 amRNSDate of announcement of Preliminary Results 2021
13th Jan 20224:40 pmRNSSecond Price Monitoring Extn
13th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Dec 20211:22 pmRNSCompletion of a small-scale targeted VEP
16th Dec 202110:27 amRNSDate of Annual General Meeting
6th Dec 20217:43 amRNSEU-wide Transparency Exercise 2021
1st Dec 20217:00 amRNSDecision to call Tier 2 Capital Notes
30th Nov 202111:51 amRNSAppointment of New Director
30th Nov 202110:32 amRNSGroup Financial Results for 9M2021 - Replacement
30th Nov 20217:04 amRNSDoc re. (9M2021 Presentation Announcement)
30th Nov 20217:00 amRNSGroup Financial Results for 9M2021
19th Nov 20218:25 amRNSDate of Announcement of 9M2021 FR
15th Nov 20217:00 amRNSAgreement for sale of a portfolio of NPLs
8th Nov 20214:41 pmRNSSecond Price Monitoring Extn
8th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Oct 20214:35 pmRNSPrice Monitoring Extension
8th Oct 202112:10 pmRNSBuyback of Tier 2 Capital Notes
7th Oct 202111:57 amRNSAppointment of New Director
30th Sep 20218:32 amRNSTR-1 Notification- Caius
16th Sep 20217:33 amRNSTR-1 Notification -Senvest
13th Sep 202112:00 pmRNSTR-1 Notification - Carval
9th Sep 20214:41 pmRNSSecond Price Monitoring Extn
9th Sep 20214:36 pmRNSPrice Monitoring Extension
8th Sep 20214:40 pmRNSSecond Price Monitoring Extn
8th Sep 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.